CA3079916A1 — Pharmaceutical composition containing quinoline derivative
Assigned to Jiangsu Hengrui Medicine Co Ltd · Expires 2019-05-02 · 7y expired
What this patent protects
The present invention provides a pharmaceutical composition containing a quinoline derivative. In particular, the present invention provides a method for preparing a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyqui…
USPTO Abstract
The present invention provides a pharmaceutical composition containing a quinoline derivative. In particular, the present invention provides a method for preparing a pharmaceutical composition containing (R,E)-N-(4-(3-chloro-4-(pyridin-2-ylmethoxy)phenylamino)-3-cyano-7-ethoxyquinolin-6-yl)-3-(1-methylpyrrolidin-2-yl)-acrylamide or a pharmacologically acceptable salt thereof. The preparation method is suitable for industrial mass production, and the resultant sample has characteristics of rapid dissolution, uniform dissolution, etc.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.